Scott Coiante Insider Profile

Scott Coiante, CFO at Agile Therapeutics, holds 20.08K shares in Agile Therapeutics (Ticker: AGRX), holds 145.06K shares in Aprea Therapeutics (Ticker: APRE).
Scott Coiante

Scott Coiante
Agile Therapeutics (AGRX)

Not Ranked
Scott Coiante has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Scott Coiante's holdings

Insider Roles

Aprea Therapeutics
Agile Therapeutics
Roles that Scott Coiante holds in companies

Most Profitable Insider Trade

Aprea Therapeutics
Rating:Informative Buy
Date:Oct 07, 2019 - Oct 07, 2020
The most profitable trade made by Scott Coiante

Scott Coiante's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agile Therapeutics
Oct 04, 2023
Uninformative Buy
Aprea Therapeutics
Aug 01, 2022
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Scott Coiante's performance on stock

Scott Coiante insider profile FAQ

What is the percentage of profitable transactions made by Scott Coiante?
The percentage of profitable transactions made by Scott Coiante is ―.
    What is the average return per transaction made by Scott Coiante?
    The average return per transaction made by Scott Coiante is ―.
      What stocks does Scott Coiante hold?
      Scott Coiante holds: AGRX, APRE stocks.
        What was Scott Coiante’s latest transaction?
        Scott Coiante latest transaction was an Uninformative Buy of ―.
          What was Scott Coiante's most profitable transaction?
          Scott Coiante’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
            What is Scott Coiante's role in Agile Therapeutics?
            Scott Coiante's role in Agile Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.